Give millions more weight loss jabs, MPs demand - as report shows just 6% of eligible patients are offered Mounjaro

Read the original at Daily Mail ↗
Cite

Foreman, C. (2026, October 22). Give millions more weight loss jabs, MPs demand - as report shows just 6% of eligible patients are offered Mounjaro. Daily Mail. https://www.dailymail.com/health/article-16229435/weight-loss-jabs-rollout-mounjaro.html?ns_mchannel=rss&ns_campaign=1490&ito=1490

Dated from the outlet's own feed. Check the original for its byline.

Daily Mail · collected 2026-10-23 · by Ciaran Foreman

Quick Summary

MPs are urging the UK government to offer millions more Britons the weight loss injection Mounjaro on the NHS, as a cross-party report reveals that only 6% of eligible patients will receive it under the current three-year rollout plan beginning in 2024. The Health and Social Care Committee (HSCC) criticizes this approach as insufficient given the high demand for the treatment, which costs around £300 per month when obtained privately, leading to a two-tier system that excludes many who need it most.
Written locally by qwen2.5:14b on 2026-10-23, using this article's own text rather than the other coverage of the same event (that is the story summary below).

AI analysis runs on qwen2.5:14b, locally

Story summary

Millions more Britons should be offered the weight loss injection Mounjaro through the NHS, MPs have demanded. A recent cross-party report reveals that only 6% of eligible patients are currently receiving the drug as part of a three-year rollout that began in 2024. The Health and Social Care Committee (HSCC) warned that this shortage could drive desperate patients to seek black market alternatives or plunge into debt by paying upwards of £300 monthly for private access, creating a "two-tier system." Mounjaro, approved by the National Institute for Health and Care Excellence (NICE) in late 2024, was initially planned to be rolled out gradually to accommodate high demand, with an initial commitment to deliver it to 200,000 patients over three years. However, MPs argue that this rollout is insufficient, leading to potential serious health risks and financial burdens for those seeking treatment.

Written for “MPs Demand More Weight Loss Jabs” on 2026-10-23, grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
The model judged this article politically coded and scored it -0.65, but 1 quote(s) could not be found in the article and the other 2 are attributed speech rather than the article's own narration, so the score is not published.
Written under an earlier scoring contract, which gave a paragraph rather than checkable quotes. Re-analysing this article replaces it.
Leaning score withheld for article 100884: no verified evidence · logged 2026-10-23

Story

📰 MPs Demand More Weight Loss Jabs
Politics · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
35
sentences that state something as happening or true
Uncertain
20%
7 of 35 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
64/100
Daily Mail's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-23 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Daily Mail · 7043 article(s) · 15 correction(s) detected
Running correction rate · 15 correction(s)

Who wrote this

Ciaran Foreman
7 article(s) here · 1 carrying a prediction
🔮 A damning cross-party report shows just 6 per cent of the millions of eligible patients will get access to the injections as part of the NHS' three year roll-out, which began in 2024.
🔮 A blood test that could predict prostate cancer more than a decade before diagnosis is a step closer, after scientists discovered a new way to identify men at risk of the disease.
🔮 Consumer watchdog Which? found that shoppers could save hundreds of pounds a year by switching to old-fashioned tablets or capsules.
🔮 Reassuringly, experts have told the Daily Mail that those who've used sunbeds in their early life will not inevitably develop melanoma, which kills around 2,600 Britons every year.
🔮 Experts from the charity say it could take until 2032 to reach the target unless care improves.
🔮 But he warned that soaring obesity rates and diets increasingly high in processed meat could also be playing a role.
🔮 Food safety chiefs are urging Britons to avoid 'raw or lightly cooked egg' products such as mousses, mayonnaise or hollandaise sauce.
Also by Ciaran Foreman
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 7 articles by Ciaran Foreman →

Topics

Britons HSCC Mounjaro NHS The Health and Social Care Committee

Subjects

NHS ORG · 12× HSCC ORG · 3× Britons NORP · 1× English NORP · 1× Government ORG · 1× Layla Moran PERSON · 1× NICE ORG · 1× National Institute for Health and Care Excellence ORG · 1× The Health and Social Care Committee ORG · 1×

Narrative

'We expect NHS Integrated Care Boards to be making these drugs available as part of a phased rollout, starting with people in the greatest clinical need, while building the workforce and capacity needed to expand access safely and sustainably.
framing: assertive · carried by 1 article(s) · first seen 2026-10-23
🔮 A damning cross-party report shows just 6 per cent of the millions of eligible patients will get access to the injections as part of the NHS' three year roll-out, which began in 2024.

Claims (35 extracted, 7 hedged)

Millions more Britons should be offered the blockbuster weight loss jab Mounjaro on the NHS , MPs have warned the Government. asserted
MPs → offer → Government
A damning cross-party report shows just 6 per cent of the millions of eligible patients will get access to the injections as part of the NHS' three year roll-out, which began in 2024. asserted
which → show → 2024
The Health and Social Care Committee (HSCC) warned that the 'woeful' situation will likely drive many desperate patients to turn to the black market, risking serious harm. asserted
situation → warn → harm
Meanwhile, others seeking access to the treatments privately are plunging into debt to do so by spending upwards of £300 a month. asserted
others → seek → 300
This has created what MPs described as a 'two-tier system' that may block those at greatest need from affording treatment. uncertain
that → create → treatment
Mounjaro – referred to as the 'King Kong' of slimming jabs – was approved for use by NHS drug watchdogs in late 2024. asserted
Mounjaro → refer → 2024
National Institute for Health and Care Excellence (NICE) promised a gradual roll out, committing to delivering the drug to 200,000 patients over the course of three years. asserted
Institute → promise → years
The staggered access was said to allow the NHS to cope with high demand and avoid placing undue pressure on GPs services. asserted
NHS → say → services
The rollout of the blockbuster fat jab Mounjaro on the NHS is 'unambitious', MPs have warned However, MPs say the target does not go far enough. asserted
target → warn → NHS
'Current plans to rollout Mounjaro are unambitious given the scale of the challenge of obesity and reach a woefully small number of people who could benefit from this lifechanging treatment,' MPs wrote in the HSCC report. uncertain
MPs → rollout → report
'We acknowledge there are challenges relating to capacity and funding. asserted
We → acknowledge → capacity
However, given the much larger number of private prescriptions of GLP-1s, we believe there are opportunities to learn from the private sector and better use the capacity of digital providers. asserted
we → give → providers
'The system needs to be designed to support wider access now and be ready for the future. asserted
system → need → future
The HSCC argued that expanding NHS access to the drugs could prevent dangerous complications from obesity. uncertain
expanding → argue → obesity
Committee chairwoman Layla Moran said this could 'save the NHS billions in the long-term'. uncertain
this → say → term
Obesity – classed when a person has a body mass index (BMI) of more than 30 – costs the UK economy more than £74billion a year, and the NHS more than £9billion. asserted
person → class → 9billion
Around two-thirds of English adults are classed as overweight or obese. asserted
thirds → class → adults
MPs are now calling on the Government to 'urgently reassess the pace of rollout of Mounjaro'. asserted
MPs → call → Mounjaro
It is the most powerful approved weight loss jab, helping patients shed around a fifth of their body weight after 17 months. But currently, patients must meet strict criteria before being given weight loss jabs on the NHS. asserted
patients → approve → NHS
Mounjaro can be prescribed by GPs to people who are severely obese – a BMI of more than 35 – who also have at least four serious weight-related health conditions like type 2 diabetes, heart disease, sleep apnoea and high cholesterol. asserted
who → prescribe → diabetes
Wegovy, meanwhile, can only be accessed through specialist weight-management clinics and cannot be prescribed by a GP. asserted
Wegovy → access → GP
Another popular jab, Ozempic, is prescribed on the NHS for type 2 diabetes rather than obesity. asserted
jab → prescribe → diabetes
The report did not propose specific changes to prescribing criteria for GLP-1s, but MPs said more could be done to improve access to obesity treatment more widely. uncertain
more → propose → treatment
Instead of every patient needing repeated GP appointments, for example, they suggested that the NHS could work with already approved digital providers. uncertain
NHS → need → providers
These could help to prescribe, monitor and support people taking weight-loss drugs at scale – freeing up NHS capacity while expanding access. uncertain
These → help → access
They also argued that a significant change would be recognising obesity as a chronic, relapsing disease that needs treating, similar to conditions such as type 2 diabetes and asthma, rather than being viewed as a lifestyle issue. asserted
that → argue → issue
Furthermore, MPs called for greater use of bariatric surgery, which they branded a 'cost-effective underutilised treatment for obesity'. asserted
they → call → obesity
They said just 6,550 procedures were carried out in 2024-25, reaching fewer than 1 per cent of eligible patients, and called for this to be doubled. asserted
this → say → patients
The committee also warned of a 'postcode lottery' emerging, with access to specialist services and surgery varying depending on where patients live. asserted
patients → warn → services
Overall, the report concluded that 'people living with obesity are being let down by the NHS'. asserted
people → conclude → NHS
Ms Moran said: 'Our report urges the Government to make improvements to obesity care a priority – both to improve public health and quality of life, and to save the NHS billions in the long-term. asserted
improvements → say → term
NHS England and the Department of Health and Social Care were approached for comment. asserted
England → approach → comment
'Obesity is one of the biggest challenges facing our health service, and this government is determined to end the obesity epidemic to help drive the shift from sickness to prevention. asserted
government → face → prevention
'We expect NHS Integrated Care Boards to be making these drugs available as part of a phased rollout, starting with people in the greatest clinical need, while building the workforce and capacity needed to expand access safely and sustainably. asserted
drugs → expect → access
'We will carefully consider the Committee's recommendations and respond in due course.' asserted
We → consider → course
💬Give feedback
🕘History 🎫Support